Navigation Links
Sally Jessy Raphael Bids Farewell to Her Infamous Red Glasses, Reports Green Nest
Date:3/16/2009

Looking for a greener earth day resolution in 2009? Join media mogul Sally Jessy Raphael with Green Nest LLC co-founder and healthy living expert Lisa Beres as they take listeners on a journey of seeing their own homes through a greener lens.

IRVINE, Calif., March 16 /PRNewswire/ -- When you set out to work on your Earth Day 2009 resolution to clean out the garage or the upstairs closet, digging through an avalanche of junk should not be your biggest worry. According to Building Biologist Lisa Beres, "Clutter isn't the real enemy -- it's the toxic products we live with everyday. Many ordinary products like cleaners, paint, and even bedding can leach toxic chemicals into the air and onto your skin. These chemicals may end up making you and your family sick." Certified Green Building Professional Lisa Beres and radio talk show host Sally Jessy Raphael announce the release of their new 3-pack CD titled Your Home Through Green Colored Glasses. The entertaining yet information-packed CD collection "guides the audience through the use of their five senses into the adventure of a healthier lifestyle while assisting consumers in identifying which products put you at risk. Simply put, it demonstrates how to clean up your house and your life in a more responsible way," reports Beres. Lisa and Sally also discuss the health risks of remodeling your home, cell phones, pesticides, cosmetics, cleaning products and how Lisa herself overcame environmental illness. Beres guides the audience in using both common sense and our five senses to tune into the daily harmful effects of these inconspicuous products while simultaneously replacing toxic habits with healthy eco-friendly ones.

The CD set is a compilation of the most popular green living show segments featured on the radio show currently broadcast on XM radio channel 158 and Sally Jessy Raphael's website http://www.sallyjr.com.

'/>"/>

SOURCE Green Nest LLC
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Sally W. Crawford Joins Insulets Board of Directors
2. Three-Time Grammy Nominee Raphael Saadiq to Perform at 17th Annual Elton John AIDS Foundation Academy Awards(R) Viewing Party
3. American Fertility Association Bids Farewell to Founding Executive Director
4. Farewell chicken tenders
5. Orchid Cellmark Reports Fourth Quarter and Full Year 2008 Financial Results
6. Haemacure Reports First Quarter 2009 Results and Hires Advisor for the Sale or Merger of the Company
7. MIB Life Index Reports North American Life Insurance Activity up 1.1% in February
8. NxStage Reports Fourth Quarter and Full Year 2008 Financial Results
9. PLC Systems Reports Fourth Quarter 2008 Results
10. EntreMed Reports Fourth Quarter and Year-End 2008 Financial Results
11. Medifast Reports Record Sales and Net Income for Fiscal Year 2008
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10DSS Research Announces Senior Health Risk Assessment 28SrHRA 29 28TM 29 58537 1DSS Research Announces Senior Health Risk Assessment 28SrHRA 29 28TM 29 58537 2Pan American Life Insurance Group Plans to Complete Coverage in Central America With Entry Into Costa Rica 3B Company Files Request for Authorization 58534 1Pan American Life Insurance Group Plans to Complete Coverage in Central America With Entry Into Costa Rica 3B Company Files Request for Authorization 58534 2Sport Science Lab Maintains That Injury to USC Football Player is Symptomatic of the Dangers of Conventional Weight Training 58530 1Sport Science Lab Maintains That Injury to USC Football Player is Symptomatic of the Dangers of Conventional Weight Training 58530 2